{
  "report_rows": [
    {
      "kpi": "Adjusted Diluted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.88 vs. cons $2.82",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$3.01B vs. cons $2.98B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic Revenue/Volume Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~9.0% organic growth vs. cons/implied ~8.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Adjusted EPS Guidance",
      "prediction": "BETTER",
      "answer": "guide ~$10.85 (raised range midpoint) vs. cons $10.72 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Revenue Guidance",
      "prediction": "BETTER",
      "answer": "guide ~$11.90B (raised range midpoint) vs. cons $11.83B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "H2 Cost Headwinds (Project Nova dilution/fuel/weather commentary)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$0.25 EPS dilution from Nova (60%+ in H2) vs. prior guided ~$0.25 already embedded (H2 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.3,
  "day5_path": "FADE",
  "day5_rationale": "Consensus already assumes another beat-and-raise given DGX's 4-quarter beat streak and Q1 blowout, and shares sit near 52-week highs (~23x fwd EPS) after a 24.5% YTD run, so an in-line-to-modest beat is largely priced in, capping the initial pop. More importantly, management has explicitly guided H2 EPS/revenue phasing lower (just over 50% of FY EPS in H2 vs ~49% H1) due to Project Nova spend (>60% loaded into H2, ~$0.25 dilution), elevated fuel costs, and a tougher weather comp versus 2025's unusually mild season \u2014 these are real, quantified out-period drags that analysts will bake into H2/FY27 revisions even if Q2 itself beats and FY26 guidance is nudged up. That combination (priced-for-perfection setup + known H2 cost step-up + tougher YoY comps on Corewell/Fresenius contribution) points to an initial positive reaction fading over the following days as the buy-side digests the implicit margin deceleration into H2, rather than sustained follow-through.",
  "day5_confidence": "MEDIUM"
}